MENU
MYNZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Mainz Biomed (MYNZ) Ownership - Who owns Mainz Biomed?

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions... Show more

Profile

Industry
N/A
Address
Robert Koch Strasse 5
Phone
+49 61315542860
Employees
64
Web
https://www.mainzbiomed.com

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
6.55M
P/E Ratio
N/A
Total Cash
977.76K
Projected Growth
N/A
Total Debt
8.27M
Revenue
N/A
Risk (Beta)
0.48
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
0.92 USD as % of share price

Fundamentals

MYNZ
Capitalization
6.55M
P/E Ratio
N/A
Risk (Beta)
0.48
Dividend Yield
N/A
Total Cash
978K
Total Cash/Share
0.21
Total Debt
8.27M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.92%
Revenue
N/A
ROE
N/A
Book Value
-4.14M
P/B Ratio
1.08
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
276K
Current Ratio
0.24
Current Revenue Per Employee
3024.80
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
62.74
Revenue To Assets
N/A
Shares Held By Institutions
751K
Shares Outstanding - Current
4.58M
Total Liabilities
12.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-66.898
View a ticker or compare two or three
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MYNZ showed earnings on April 01, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Robert Koch Strasse 5
Phone
+49 61315542860
Employees
64
Web
https://www.mainzbiomed.com